风险因素在治疗肝脏脑病症时的关键作用
Lucia Lapenna1, Simone Di Cola1, Manuela Merli2
1Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
Metabolic brain disease
|November 21, 2024
概括
肝脏脑病变 (HE) 是肝硬化的一个常见并发症. 本次审查的重点是识别和预防HE的关键风险因素,如肝病严重程度和营养不良.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内部医学 内部医学
背景情况:
- 肝脏脑病变 (HE) 是肝硬化患者常见的并发症,通常导致失补偿.
- 过度的HE影响了30-40%的肝硬化患者在疾病期间.
- 高血压的诱发和风险因素是不同的,影响急性事件与长期易感性.
研究的目的:
- 审查肝硬化中肝脏脑病发作的重大风险因素.
- 概述预防肝脏脑病变的策略.
主要方法:
- 文献综述侧重于高等教育的风险因素.
- 对HE的沉与风险因素的分析.
- 讨论针对已识别的风险因素的预防措施.
主要成果:
- 关键的危险因素包括肝病的严重程度,先前的肝炎发作,隐蔽的肝炎,转移 (自发/催血),营养不良,慢性疗法和代谢性疾病.
- 风险因素对于高等教育预防策略至关重要.
- 区分风险和诱发因素指导管理.
结论:
- 了解和管理风险因素对于预防肝硬化中的肝脑病变至关重要.
- 针对风险因素的预防方法可以减少HE发病率.
- 早期识别和干预风险因素是患者管理的关键.
更多相关视频
相关概念视频
Hepatic Drug Excretion: Influencing Factors
86
The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
86
Factors Affecting Drug Biotransformation: Biological
112
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
112
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
98
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
98
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Factors Affecting Drug Response: Overview
1.9K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
1.9K


